Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
37
COYA Quote, Financials, Valuation and Earnings
Last price:
$4.83
Seasonality move
:
29.02%
Day range:
$4.61 - $4.87
52-week range:
$3.94 - $8.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.34x
P/B ratio:
3.72x
Volume:
83.2K
Avg. volume:
259K
1-year change:
-26.29%
Market cap:
$101.5M
Revenue:
$3.6M
EPS (TTM):
-$1.10
Earnings Data
Next earnings date for COYA
Mar 12
2026
Most recent earnings per share
-$0.13
Beat by $0.18
(Nov 12/2025)
Consensus Estimate
-$0.30
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
COYA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $206K | -- | -- | -$0.35 | -- |
| 03/12/2026 | Q4 | $1.9M | -- | -- | -$0.30 | -- |
| 11/12/2025 | Q3 | $3.7M | $3.6M | -$0.13 | -$0.30 | $0.18 |
| 08/12/2025 | Q2 | $668.6K | $163.6K | -$0.36 | -$0.43 | $0.07 |
| 05/13/2025 | Q1 | $2M | $257.9K | -$0.44 | -$0.13 | -$0.31 |
| 03/18/2025 | Q4 | $80K | $2K | -$0.17 | -$0.14 | -$0.03 |
| 11/06/2024 | Q3 | $175K | -- | -$0.26 | -- | -- |
| 08/12/2024 | Q2 | $3.9M | $3.4M | -$0.19 | -- | -- |
| 05/09/2024 | Q1 | -- | $126.8K | -$0.35 | -- | -- |
| 03/19/2024 | Q4 | $7.5M | $6M | $0.15 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | -$0.34 | -- | -- |
| 08/08/2023 | Q2 | -- | -- | -$0.31 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/29/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.42 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.52 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.26 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.25 | -- | -- |
Coya Therapeutics, Inc. Earnings Questions
-
How Much did Coya Therapeutics, Inc. Generate in Revenue Last Quarter?
Coya Therapeutics, Inc. reported $3.6M worth of top line sales in its most recent quarter.
-
Did Coya Therapeutics, Inc. Beat Earnings Last Quarter?
Coya Therapeutics, Inc. announced earnings per share of -$0.13 which represents a beat of analyst forecast a -$0.30 per share.
-
Is Coya Therapeutics, Inc. Profitable?
Coya Therapeutics, Inc. reported $3.6M that represents $0.21 per share over the last quarter.
-
What is the Analyst Consensus for Coya Therapeutics, Inc. EPS Next Year?
Coya Therapeutics, Inc.'s earnings are forecast to decrease from -$0.98 per share to -$1.22 per share next year representing a decrease of -60.78%.
-
When is Coya Therapeutics, Inc.'s Earnings Date?
Coya Therapeutics, Inc.'s next earnings date is March 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
73
HYMC alert for Feb 19
Hycroft Mining Holding Corp. [HYMC] is up 3.61% over the past day.
Buy
90
TCMD alert for Feb 19
Tactile Systems Technology, Inc. [TCMD] is down 7.32% over the past day.
Buy
57
GLBE alert for Feb 19
Global-e Online Ltd. [GLBE] is up 2.38% over the past day.
